A recent study published in the Oxford University Press journal Research Connections has found that nearly one quarter of children diagnosed with gender dysphoria in the Beaver State have been subjected to so-called “gender-affirming care” over a seven-year period.
Researchers from Comagine Health, a nonprofit health care consulting firm, analyzed multi-payer claims data from 2016 to 2023 for adolescents aged 8-17 in the Beaver State. The study reports that one in every 630 boys in Oregon received cross-sex hormones during this timeframe.
The research highlights potential adverse effects of these treatments on bone density, cognitive function, emotional stability, and future fertility. Medical professionals have raised concerns about the scientific foundation for such interventions in minors.
The findings come as the Trump administration and British government have taken steps to restrict gender-affirming care for children, but some states continue providing access without adequate oversight.
